Stockreport

Histogen Reports Second Quarter 2020 Earnings and Provides Business Update

Histogen Inc.  (HSTO) 
PDF Completed Enrollment for HST-001 Phase 1a/2b Trial for Androgenic Alopecia in Men with Topline Data Expected 4Q20Filed IDE for HST-002 for Treatment of Moderate to Sever [Read more]